These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9308633

  • 1. Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo.
    Margolis-Nunno H, Bardossy L, Robinson R, Ben-Hur E, Horowitz B, Blajchman MA.
    Transfusion; 1997 Sep; 37(9):889-95. PubMed ID: 9308633
    [Abstract] [Full Text] [Related]

  • 2. Psoralen-mediated virus photoinactivation in platelet concentrates: enhanced specificity of virus kill in the absence of shorter UVA wavelengths.
    Margolis-Nunno H, Robinson R, Horowitz B, Geacintov NE, Ben-Hur E.
    Photochem Photobiol; 1995 Nov; 62(5):917-22. PubMed ID: 8570732
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Determination of residual 4'-aminomethyl-4,5',8-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions.
    Wagner SJ, White R, Wolf L, Chapman J, Robinette D, Lawlor TE, Dodd RY.
    Photochem Photobiol; 1993 May; 57(5):819-24. PubMed ID: 8337254
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
    Grass JA, Hei DJ, Metchette K, Cimino GD, Wiesehahn GP, Corash L, Lin L.
    Blood; 1998 Mar 15; 91(6):2180-8. PubMed ID: 9490707
    [Abstract] [Full Text] [Related]

  • 7. Quencher-enhanced specificity of psoralen-photosensitized virus inactivation in platelet concentrates.
    Margolis-Nunno H, Robinson R, Ben-Hur E, Horowitz B.
    Transfusion; 1994 Sep 15; 34(9):802-10. PubMed ID: 8091471
    [Abstract] [Full Text] [Related]

  • 8. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.
    Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L.
    Transfusion; 1997 Apr 15; 37(4):423-35. PubMed ID: 9111281
    [Abstract] [Full Text] [Related]

  • 9. Inactivation of cytomegalovirus in platelet concentrates using Helinx technology.
    Lin L.
    Semin Hematol; 2001 Oct 15; 38(4 Suppl 11):27-33. PubMed ID: 11727283
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of free and cell-associated human immunodeficiency virus in platelet suspensions by aminomethyltrimethylpsoralen and ultraviolet light.
    Benade LE, Shumaker J, Xu Y, Chen X, Dodd RY.
    Transfusion; 1994 Aug 15; 34(8):680-4. PubMed ID: 8073484
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates.
    Horowitz B, Rywkin S, Margolis-Nunno H, Williams B, Geacintov N, Prince AM, Pascual D, Ragno G, Valeri CR, Huima-Byron T.
    Blood Cells; 1992 Aug 15; 18(1):141-9; discussion 150. PubMed ID: 1617188
    [Abstract] [Full Text] [Related]

  • 12. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers.
    Margolis-Nunno H, Williams B, Rywkin S, Geacintov N, Horowitz B.
    Transfusion; 1992 Aug 15; 32(6):541-7. PubMed ID: 1502707
    [Abstract] [Full Text] [Related]

  • 13. Viral inactivation in platelet concentrates.
    Dodd RY.
    Transfus Clin Biol; 1994 Aug 15; 1(3):181-6. PubMed ID: 8044313
    [Abstract] [Full Text] [Related]

  • 14. Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates.
    Corash L, Lin L, Wiesehahn G.
    Blood Cells; 1992 Aug 15; 18(1):57-73; discussion 74. PubMed ID: 1617193
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K, Lin L, Eichler H, Mayaudon V, Flament J, Klüter H.
    Vox Sang; 2004 May 15; 86(4):239-45. PubMed ID: 15144528
    [Abstract] [Full Text] [Related]

  • 19. Inactivation of Trypanosoma cruzi trypomastigote forms in blood components with a Psoralen and Ultraviolet A light.
    Gottlieb P, Margolis-Nunno H, Robinson R, Shen LG, Chimezie E, Horowitz B, Ben-Hur E.
    Photochem Photobiol; 1996 May 15; 63(5):562-5. PubMed ID: 8628745
    [Abstract] [Full Text] [Related]

  • 20. Analysis of reasons for not implementing pathogen inactivation for platelet concentrates.
    Lozano M, Cid J.
    Transfus Clin Biol; 2013 May 15; 20(2):158-64. PubMed ID: 23587612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.